The new $375,000 price tag for a once-free drug used to treat Lambert-Eaton myasthenic syndrome has led one mother to take half the prescribed dose in an effort to stretch the drug out as long as possible, CNN reports.
“The words that I can use is I can’t believe this is happening, to be honest,” Bhanu Patel told CNN.
The new drug, Catalyst Pharmaceuticals’ Firdapse, replaces the once-free drug known as 3,4-DAP, which was manufactured by Jacobus Pharmaceutical. According to the report, Jacobus’ drug was free through a specialty program until Catalyst Pharmaceuticals received the green light from the Food and Drug Administration for its modified version.
Sen. Bernie Sanders slammed Catalyst Pharmaceuticals over the drug’s price.
“Catalyst’s decision to set the annual list price at $375,000 is not only a blatant fleecing of American taxpayers, but is also an immoral exploitation of patients who need this medication,” he said. “I am profoundly concerned that Catalyst’s actions will cause patients to suffer or die.”
To read the full report on CNN, click here.